Coronation Fund Managers Ltd. Buys 7,036 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Coronation Fund Managers Ltd. increased its stake in UnitedHealth by 9%, buying 7,036 shares to hold 85,185 shares valued at about $28.12 million, representing 1.3% of its portfolio and the firm's 22nd largest holding.
• UnitedHealth reported a Q1 beat with $7.23 EPS (vs. $6.76 expected) and raised FY‑2026 guidance to about 18.25 EPS, spurring bullish momentum, heavy call‑option activity and several analyst upgrades.
• Despite the rebound, the stock faces mixed risks—Optum Health margin execution concerns, a shareholder proposal for an independent board chair, and ongoing valuation debate that could limit near‑term upside.

Coronation Fund Managers Ltd. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 9.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 85,185 shares of the healthcare conglomerate's stock after purchasing an additional 7,036 shares during the period. UnitedHealth Group makes up 1.3% of Coronation Fund Managers Ltd.'s investment portfolio, making the stock its 22nd largest holding. Coronation Fund Managers Ltd.'s holdings in UnitedHealth Group were worth $28,120,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently modified their holdings of UNH. Beacon Financial Strategies CORP bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $26,000. Foster Dykema Cabot & Partners LLC lifted its position in UnitedHealth Group by 69.4% during the 3rd quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 34 shares during the period. 1248 Management LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $29,000. Holos Integrated Wealth LLC purchased a new position in UnitedHealth Group during the 4th quarter valued at about $29,000. Finally, Hurley Capital LLC lifted its position in UnitedHealth Group by 81.6% during the 3rd quarter. Hurley Capital LLC now owns 89 shares of the healthcare conglomerate's stock valued at $31,000 after acquiring an additional 40 shares during the period. Institutional investors own 87.86% of the company's stock.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q1 beat and guidance raise: UNH reported a quarterly EPS beat and raised FY guidance, which analysts say has driven renewed momentum and a sharp short‑term share rebound. This is the primary driver behind today’s lift. A Look At UnitedHealth Group (UNH) Valuation As Q1 2026 Beat And Guidance Hike Drive Fresh Momentum
• Positive Sentiment: Prior authorization modernization: UnitedHealthcare said it will standardize a majority of electronic prior‑authorization submissions (70%+ by year‑end), reducing provider friction and potentially lowering administrative costs. This supports margin improvement expectations. UnitedHealthcare Champions Industry Effort to Standardize Prior Authorization Requirements
• Positive Sentiment: Large call‑option activity: Reported heavy buying of UNH call options signals bullish positioning from traders anticipating further upside after the earnings beat. That can amplify near‑term upward pressure on the stock. Investors Purchase Large Volume of UnitedHealth Group Call Options
• Positive Sentiment: High‑profile bullish media/analyst commentary: Jim Cramer and several outlets/analysts have highlighted UNH as a buy after the Q1 print, which is helping retail and momentum flows. Jim Cramer Says UNH at $354 Is a Steal — Here’s Why the Math Backs Him Up
• Positive Sentiment: Analyst upgrades / favorable coverage: Argus and other outlets have upgraded or upgraded coverage tone recently, adding credibility to the recovery story. Argus Research upgrades UnitedHealth Group (UNH)
• Neutral Sentiment: Valuation debate: Coverage discusses UNH’s P/E and valuation after the rebound; some view the stock as a value play now, while others caution the 1‑year TSR still lags. Valuation is driving contrasting investor views, sustaining volatility. UnitedHealth: Recovery Is Progressing, But Upside May Be Limited Near Term
• Negative Sentiment: Optum Health execution risk / limited near‑term upside: Independent analysis notes that while medical margins improved, Optum Health margins remain challenged and some recovery gains may be non‑structural—this could limit upside if operational recovery stalls. UnitedHealth: Recovery Is Progressing, But Upside May Be Limited Near Term
• Negative Sentiment: Governance proposal: A shareholder proposal seeking an independent board chair is drawing attention; the board opposes it. Governance disputes can create noise and potentially weigh on sentiment if shareholder activism grows. Independent Chair Proposal Tests Governance And Valuation Views At UnitedHealth Group
• Positive Sentiment: Rural health initiative: UNH launched a broad rural health program and prior‑authorization reductions for rural providers, strengthening growth/PR narrative in underserved markets. UnitedHealth Group Incorporated (UNH) Launches Broad Rural Health Initiative to Strengthen Underserved Communities
• Negative Sentiment: Mixed analyst notes: A recent price‑target adjustment (TD Cowen raise to $337 but maintained Hold) implies limited near‑term upside from some sell‑side desks—this can temper aggressive buy calls. TD Cowen raises price target to $337 (Hold)

UnitedHealth Group Stock Up 0.1%

Shares of UnitedHealth Group stock opened at $355.05 on Friday. The company has a 50-day simple moving average of $293.40 and a two-hundred day simple moving average of $317.33. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $424.12. The stock has a market capitalization of $322.46 billion, a PE ratio of 26.82, a price-to-earnings-growth ratio of 1.53 and a beta of 0.40. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.80.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, topping analysts' consensus estimates of $6.76 by $0.47. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The firm had revenue of $111.65 billion during the quarter, compared to analyst estimates of $109.84 billion. During the same period in the previous year, the business posted $7.20 earnings per share. The business's revenue for the quarter was up 2.0% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a $2.21 dividend. The ex-dividend date was Monday, March 9th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group's payout ratio is currently 66.77%.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. TD Cowen lifted their price target on shares of UnitedHealth Group from $311.00 to $337.00 and gave the company a "hold" rating in a research report on Thursday. Mizuho lowered their price target on shares of UnitedHealth Group from $430.00 to $350.00 and set an "outperform" rating for the company in a research report on Thursday, February 5th. Barclays lifted their price target on shares of UnitedHealth Group from $327.00 to $373.00 and gave the company an "overweight" rating in a research report on Wednesday. Evercore raised shares of UnitedHealth Group to a "strong-buy" rating in a report on Tuesday, January 6th. Finally, Weiss Ratings cut shares of UnitedHealth Group from a "hold (c-)" rating to a "sell (d+)" rating in a report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $377.64.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.